Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide-Reference-Cited by-同舟云学术

Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide

Published:2024-09-12 Issue:1 Volume:16 Page:
ISSN:1949-0976
Container-title:Gut Microbes
language:en
Short-container-title:Gut Microbes

Author:

Tang Dafu¹,Hu Wanyu¹,Fu Bingxuan¹,Zhao Xiaojie¹,You Guoquan¹,Xie Cong²,Wang Hong Yu¹,Guo Xueni¹,Zhang Qianbing³,Liu Zhongqiu¹⁴,Ye Ling¹^ORCID

Affiliation:

1. NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China

2. Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China

3. Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China

4. International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China

Funder

National Natural Science Foundation of China

Guangdong Basic and Applied Basic Research Foundation

Science and Technology Innovation Project of Guangdong Medical Products Administration

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/19490976.2024.2387402

Reference80 articles.

1. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines

2. Current pharmacotherapy for cholestatic liver disease

3. Multicentre Survey of the Prevalence of Intrahepatic Cholestasis in 2520 Consecutive Patients with Newly Diagnosed Chronic Liver Disease

4. Primary biliary cholangitis: Old and novel therapy

5. Primary biliary cholangitis